Pituitary adenoma surgery

Revision as of 19:02, 30 September 2015 by Ahmad Al Maradni (talk | contribs)
Jump to navigation Jump to search

Pituitary adenoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pituitary adenoma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural history, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pituitary adenoma surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pituitary adenoma surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pituitary adenoma surgery

CDC on Pituitary adenoma surgery

Pituitary adenoma surgery in the news

Blogs on Pituitary adenoma surgery

Directions to Hospitals Treating Pituitary adenoma

Risk calculators and risk factors for Pituitary adenoma surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]

Overview

The transsphenoidal microsugrical approach is the mainstay of treatment for growth hormone-(GH) producing, adrenocorticotropic hormone-(ACTH) producing, and macroadenomas.

Surgery

Surgical treatment and contraindication for pituitary adenoma:

  • Rapid deterioration of vision is considered as an immediate indication for surgery to relieve pressure produced by an expanding tumor mass.
  • The transsphenoidal microsurgical approach to a pituitary lesion is the most widely employed surgical approach to pituitary lesions and represents a major development in the safe surgical treatment of both hormonally active and nonfunctioning tumors.
  • This approach is often successful in debulking tumors, even those that have a significant suprasellar extension (without hourglass-shape appearance).
  • The contraindications to transsphenoidal microsurgical approach include:
  • Tumors with a significant suprasellar extension with an hourglass-shaped narrowing between the intrasellar and suprasellar component, blind attempts to reach the suprasellar tumor may lead to cerebral damage.
  • An infection in the sphenoid sinus
  • Craniotomies via a pterional or subfrontal approach may be performed if transsphenoidal microsurgical approach is contraindicated.

References